Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer-Reference-Cited by-同舟云学术

Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer

Published:2011-10 Issue:7 Volume:38 Page:969-978
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Peterson Lanell M.,Kurland Brenda F.,Link Jeanne M.,Schubert Erin K.,Stekhova Svetlana,Linden Hannah M.,Mankoff David A.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference28 articles.

1. Breast cancer: PET imaging of estrogen receptors;Mintun;Radiology,1988

2. Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol;Peterson;J Nucl Med,2008

3. Tumor receptor imaging;Mankoff;J Nucl Med,2008

4. Serum oestradiol and breast cancer risk;Key;Endocr Relat Cancer,1999

5. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women;Zeleniuch-Jacquotte;Cancer Epidemiol Biomarkers Prev,1995

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology;Scientific Reports;2024-06-20

2. Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer;EJNMMI Research;2024-03-04

3. 18F-FES;Radiopharmaceuticals;2024

4. Head-to-head comparison of 18F-FDG and 18F-FES PET/CT for initial staging of ER-positive breast cancer patients;European Journal of Hybrid Imaging;2023-12-18

5. The Application of 18F-FES PET in Clinical Cancer Care;Clinical Nuclear Medicine;2023-07-22